| Fluorocurcumins as cyclooxygenase-2 inhibitor: molecular docking, pharmacokinetics and tissue distribution in mice S Padhye, S Banerjee, D Chavan, S Pandye, KV Swamy, S Ali, J Li, ... Pharmaceutical research 26, 2438-2445, 2009 | 167 | 2009 |
| Inclusion Complex of Novel Curcumin Analogue CDF and β-Cyclodextrin (1:2) and Its Enhanced In Vivo Anticancer Activity Against Pancreatic Cancer PR Dandawate, A Vyas, A Ahmad, S Banerjee, J Deshpande, KV Swamy, ... Pharmaceutical research 29, 1775-1786, 2012 | 150 | 2012 |
| Perspectives on chemopreventive and therapeutic potential of curcumin analogs in medicinal chemistry S Padhye, D Chavan, S Pandey, J Deshpande, KV Swamy, FH Sarkar Mini reviews in medicinal chemistry 10 (5), 372-387, 2010 | 150 | 2010 |
| Synthesis, characterization, molecular docking and cytotoxic activity of novel plumbagin hydrazones against breast cancer cells P Dandawate, E Khan, S Padhye, H Gaba, S Sinha, J Deshpande, ... Bioorganic & medicinal chemistry letters 22 (9), 3104-3108, 2012 | 113 | 2012 |
| Molecular docking and simulation studies on SARS-CoV-2 Mpro reveals Mitoxantrone, Leucovorin, Birinapant, and Dynasore as potent drugs against COVID-19 KB Lokhande, S Doiphode, R Vyas, KV Swamy Journal of Biomolecular Structure and Dynamics 39 (18), 7294-7305, 2021 | 104 | 2021 |
| Fluorinated 2′-hydroxychalcones as garcinol analogs with enhanced antioxidant and anticancer activities S Padhye, A Ahmad, N Oswal, P Dandawate, RA Rub, J Deshpande, ... Bioorganic & Medicinal Chemistry Letters 20 (19), 5818-5821, 2010 | 78 | 2010 |
| Synthesis, characterization and anti-tumor activity of novel thymoquinone analogs against pancreatic cancer M Yusufi, S Banerjee, M Mohammad, S Khatal, KV Swamy, EM Khan, ... Bioorganic & medicinal chemistry letters 23 (10), 3101-3104, 2013 | 67 | 2013 |
| Novel dual cyclooxygenase and lipoxygenase inhibitors targeting hyaluronan–CD44v6 pathway and inducing cytotoxicity in colon cancer cells S Misra, S Ghatak, N Patil, P Dandawate, V Ambike, S Adsule, D Unni, ... Bioorganic & medicinal chemistry 21 (9), 2551-2559, 2013 | 58 | 2013 |
| Novel di-tertiary-butyl phenylhydrazones as dual cyclooxygenase-2/5-lipoxygenase inhibitors: Synthesis, COX/LOX inhibition, molecular modeling, and insights into their … S Ghatak, A Vyas, S Misra, P O’Brien, A Zambre, VM Fresco, ... Bioorganic & medicinal chemistry letters 24 (1), 317-324, 2014 | 49 | 2014 |
| Novel Aza-resveratrol analogs: synthesis, characterization and anticancer activity against breast cancer cell lines A Siddiqui, P Dandawate, R Rub, S Padhye, S Aphale, A Moghe, ... Bioorganic & medicinal chemistry letters 23 (3), 635-640, 2013 | 46 | 2013 |
| Synthesis and characterization of pyruvate–isoniazid analogs and their copper complexes as potential ICL inhibitors D Shingnapurkar, P Dandawate, CE Anson, AK Powell, Z Afrasiabi, ... Bioorganic & medicinal chemistry letters 22 (9), 3172-3176, 2012 | 44 | 2012 |
| Molecular interaction studies of Deguelin and its derivatives with Cyclin D1 and Cyclin E in cancer cell signaling pathway: The computational approach KB Lokhande, S Nagar, KV Swamy Scientific reports 9 (1), 1778, 2019 | 40 | 2019 |
| Sensing the interactions between carbohydrate-binding agents and N-linked glycans of SARS-CoV-2 spike glycoprotein using molecular docking and simulation … KB Lokhande, GR Apte, A Shrivastava, A Singh, JK Pal, KV Swamy, ... Journal of Biomolecular Structure and Dynamics 40 (9), 3880-3898, 2022 | 36 | 2022 |
| Probing intermolecular interactions and binding stability of kaempferol, quercetin and resveratrol derivatives with PPAR-γ: docking, molecular dynamics and MM/GBSA approach to … KB Lokhande, S Ballav, RS Yadav, KV Swamy, S Basu Journal of Biomolecular Structure and Dynamics 40 (3), 971-981, 2022 | 36 | 2022 |
| Synthesis, characterization, molecular docking and anti-tubercular activity of Plumbagin–Isoniazid Analog and its β-cyclodextrin conjugate P Dandawate, K Vemuri, KV Swamy, EM Khan, M Sritharan, S Padhye Bioorganic & Medicinal Chemistry Letters 24 (21), 5070-5075, 2014 | 36 | 2014 |
| Indole: A novel signaling molecule and its applications R Pandey, KV Swamy, MB Khetmalas NISCAIR-CSIR, India, 2013 | 32 | 2013 |
| Antioxidant, anti-quorum sensing, biofilm inhibitory activities and chemical composition of Patchouli essential oil: in vitro and in silico approach A Mansuri, K Lokhande, S Kore, S Gaikwad, N Nawani, KV Swamy, ... Journal of Biomolecular Structure and Dynamics 40 (1), 154-165, 2022 | 31 | 2022 |
| Exploring conformational changes of PPAR-Ɣ complexed with novel kaempferol, quercetin, and resveratrol derivatives to understand binding mode assessment: a small-molecule … KB Lokhande, S Ballav, N Thosar, KV Swamy, S Basu Journal of Molecular Modeling 26, 1-12, 2020 | 22 | 2020 |
| Molecular modeling, docking, dynamics and simulation of gefitinib and its derivatives with EGFR in non-small cell lung cancer PS Reddy, KB Lokhande, S Nagar, VD Reddy, PS Murthy, KV Swamy Current computer-aided drug design 14 (3), 246-252, 2018 | 22 | 2018 |
| An in silico scientific basis for LL‐37 as a therapeutic for Covid‐19 KB Lokhande, T Banerjee, KV Swamy, P Ghosh, M Deshpande Proteins: Structure, Function, and Bioinformatics 90 (5), 1029-1043, 2022 | 21 | 2022 |
Prasad DandawateAssistant Professor, Cancer Biology, University of Kansas Medical CenterVerified email at kumc.edu
